Safety and efficacy of protamine in the reversal of heparin in transcatheter aortic valve replacement

J Cardiol. 2024 Aug;84(2):143-145. doi: 10.1016/j.jjcc.2024.04.008. Epub 2024 May 1.

Authors

Paul Y Lee¹, Rohan Viswanathan², Talha Chaudhry², Afif Hossain³, Thomas Lee², Abhishek Sharma³, Joseph Allencherril⁴

Affiliations

¹ Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA. Electronic address: [email protected].
² Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
³ Division of Cardiology, Rutgers New Jersey Medical School, Newark, NJ, USA.
⁴ Department of Medicine, University of Texas Medical Branch, Galveston, TX, USA.

PMID: 38701946
DOI: 10.1016/j.jjcc.2024.04.008

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Anticoagulants / administration & dosage
Anticoagulants / adverse effects
Aortic Valve Stenosis / surgery
Female
Heparin Antagonists* / administration & dosage
Heparin* / administration & dosage
Heparin* / adverse effects
Humans
Male
Protamines* / administration & dosage
Transcatheter Aortic Valve Replacement*
Treatment Outcome

Substances

Protamines
Heparin Antagonists
Heparin
Anticoagulants